title: Hepatocellular carcinoma.
abstract: Hepatocellular carcinoma is the most common cancer in males. Surgery is the only curative treatment, but is applicable in only 10-15% of patients. Systemic chemotherapy, transarterial embolization or chemo-embolization can only palliate. In the future, selective internal radiation may have a role in downstaging inoperable hepatoma to operable tumour.
authors.affiliation: Department of Surgery, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
authors.forename: W Y
authors.initials: WY
authors.lastname: Lau
authors.forename: C K
authors.initials: CK
authors.lastname: Leow
authors.forename: A K
authors.initials: AK
authors.lastname: Li
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000628:therapy; D004621:Embolization, Therapeutic; D015981:Epidemiologic Factors; D000431:Ethanol / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000431:Ethanol